Compare AVY & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVY | COO |
|---|---|---|
| Founded | 1935 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 11.6B |
| IPO Year | 1994 | 1994 |
| Metric | AVY | COO |
|---|---|---|
| Price | $156.93 | $61.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $205.56 | $90.18 |
| AVG Volume (30 Days) | 579.3K | ★ 2.1M |
| Earning Date | 04-28-2026 | 05-28-2026 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | ★ 0.69 | N/A |
| EPS | ★ 2.18 | 0.66 |
| Revenue | N/A | ★ $2,532,800,000.00 |
| Revenue This Year | $5.70 | $6.66 |
| Revenue Next Year | $3.66 | $5.18 |
| P/E Ratio | ★ $71.72 | $90.53 |
| Revenue Growth | N/A | ★ 18.41 |
| 52 Week Low | $156.13 | $58.89 |
| 52 Week High | $199.54 | $89.83 |
| Indicator | AVY | COO |
|---|---|---|
| Relative Strength Index (RSI) | 35.22 | 37.95 |
| Support Level | N/A | N/A |
| Resistance Level | $178.47 | $70.01 |
| Average True Range (ATR) | 3.48 | 1.58 |
| MACD | -0.46 | 0.24 |
| Stochastic Oscillator | 7.14 | 49.07 |
Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.